Related Experiment Videos

Macrophages secrete a heparin-binding inhibitor of endothelial cell growth

G E Besner1, M Klagsbrun

  • 1Department of Surgery, Childrens Hospital, Boston, Massachusetts 02115.

Microvascular Research
|September 1, 1991
PubMed

Insights

Macrophages secrete a novel inhibitor that regulates endothelial cell (EC) proliferation and angiogenesis. This macrophage-derived endothelial cell inhibitor (MD-ECI) affects basal and FGF-stimulated EC growth.

Area of Science:

  • Cell Biology
  • Immunology
  • Angiogenesis Research

Background:

  • Macrophages are implicated in regulating angiogenesis via secreted factors.
  • Endothelial cell (EC) proliferation is a key component of angiogenesis.

Purpose of the Study:

  • To investigate the role of macrophages in regulating EC proliferation.
  • To identify and characterize novel mediators of EC growth secreted by macrophages.

Main Methods:

  • Human mononuclear cells were cultured, and conditioned media analyzed.
  • Heparin-Sepharose affinity chromatography was used to isolate active fractions.
  • Endothelial cell proliferation assays determined growth modulation.

Main Results:

  • A novel EC growth-inhibitory activity, macrophage-derived endothelial cell inhibitor (MD-ECI), was identified.
  • MD-ECI elutes at 1.0 M NaCl from heparin-Sepharose and is secreted by macrophages.
  • MD-ECI is distinct from TGF-beta and TNF-alpha, inhibiting both basal and FGF-stimulated EC growth in a dose-dependent, non-toxic, and reversible manner.

Conclusions:

  • Macrophages secrete MD-ECI, a potent regulator of endothelial cell proliferation.
  • MD-ECI represents a new factor involved in the complex process of angiogenesis.
  • Further research into MD-ECI may reveal therapeutic targets for angiogenesis-related diseases.

Related Concept Videos